Lion's Mane vs Ashwagandha: The NGF-Cortisol Effect Explained

Most People Are Asking the Wrong Question

"Lion's Mane or Ashwagandha — which one should I take?"

We get this every week. And while it's a fair place to start, it frames two fundamentally different botanicals as if they were competing options in the same category. They're not. Lion's Mane (Hericium erinaceus) is a medicinal mushroom that acts on your neural architecture. Ashwagandha (Withania somnifera) is an Ayurvedic adaptogenic root that acts on your stress-response system. Asking which is "better" is like asking whether a hammer is better than a screwdriver.

We call this The NGF-Cortisol Effect: Lion's Mane stimulates Nerve Growth Factor (NGF), supporting the growth, repair, and protection of neurons. Ashwagandha modulates cortisol — your primary stress hormone — and supports the hypothalamic-pituitary-adrenal (HPA) axis. One tends to the hardware. The other calms the operating system so it can function at all.

In this article, we compare both through the lens of published human evidence, clarify what each does and does not do, and explain when taking both together makes sense — and when it doesn't.

Lion's Mane: The Neuroscience of NGF

Lion's Mane produces two families of unique bioactive compounds — hericenones (from the fruiting body) and erinacines (from the mycelium). Both have demonstrated the ability to stimulate the synthesis of Nerve Growth Factor in vitro and in animal models. NGF is a signalling protein essential for the growth, maintenance, and survival of neurons, particularly in the hippocampus — the brain region central to learning, memory, and spatial navigation.

This mechanism has led to substantial interest in Lion's Mane as a neuroprotective agent, and a growing body of human research is beginning to support that interest.

What the RCTs Show

In a 2023 double-blind RCT (PMID: 38004235, n=41), healthy young adults taking Lion's Mane for 28 days showed improved cognitive performance and reduced subjective stress compared to placebo. The study was notable for its healthy population — most Lion's Mane trials to that point had focused on older or cognitively impaired participants.

A 2025 RCT (PMID: 40276537) examined acute effects of a standardised Lion's Mane extract in healthy younger adults using a double-blind, placebo-controlled design. The study confirmed measurable cognitive and mood effects within hours of a single dose, linking these specifically to hericenone and erinacine content. This is one of the few human studies to demonstrate acute, rather than only chronic, effects.

The landmark cognitive decline study (PMID: 32581767) examined patients with mild Alzheimer's Disease over 49 weeks. Those receiving erinacine A-enriched Lion's Mane mycelium (350mg capsules × 3 daily) showed significantly better outcomes on cognitive assessments than the placebo group. This was a double-blind, placebo-controlled design with a longer duration than most mushroom research.

An earlier RCT (PMID: 31413233) in adults with mild cognitive impairment found significant improvements at weeks 8, 12, and 16, with cognitive scores declining again four weeks after supplementation ceased — suggesting the effect was ongoing rather than permanent, and possibly dose-dependent.

What the Evidence Does Not Yet Show

Not all findings have been positive. One clinical study (PMID: 36582308) found no improvement in cognition or metabolic flexibility after four weeks of supplementation — though the study was limited by its short duration and small sample. Of 571 published studies, only 33 are in humans, and most human trials involve small participant numbers (n < 50). Long-term data beyond 16 weeks in healthy populations remains limited. No Cochrane systematic review exists for Lion's Mane.

An important honesty note on animal research: Much of the mechanistic evidence for Lion's Mane — particularly NGF stimulation and anxiolytic effects — comes from animal studies. Of 571 published studies, only 33 involved human participants. Animal studies suggest mechanisms and guide hypotheses; they do not confirm outcomes in humans. Human evidence is limited compared to more established supplements. We present human RCT data first, and flag animal-derived evidence clearly throughout this article.

Two studies specifically merit transparent reporting: the study finding no significant effect on cognition after four weeks (PMID: 36582308), and the 2025 ashwagandha meta-analysis finding that cortisol did not improve perceived stress scores consistently (PMID: 40746175). Both are included because honest interpretation of the evidence requires acknowledging what the research did not find — not only what it did.

Ashwagandha: The Adaptogen and the HPA Axis

Ashwagandha root has been used in Ayurvedic medicine for over 3,000 years as a rasayana — a rejuvenating tonic. Its primary bioactives, withanolides, are steroidal lactones concentrated in the root. These compounds interact with the hypothalamic-pituitary-adrenal (HPA) axis, influencing how your body produces and responds to cortisol during stress.

Unlike Lion's Mane, which targets a specific neural growth mechanism, ashwagandha's effects are more systemic — acting on stress physiology, sleep architecture, physical performance, and immune function, all downstream effects of modulating the HPA axis.

The Evidence Base: More Mature, More Nuanced

Ashwagandha has a substantially larger research base: 1,584 published studies, 29 RCTs, and 21 systematic reviews. This depth allows for more confident conclusions — and also reveals important nuance.

A 2024 meta-analysis (PMID: 39348746) pooling data across multiple RCTs confirmed that ashwagandha significantly reduced perceived stress and anxiety compared to placebo. The effect size was meaningful and consistent across studies.

However, a 2025 meta-analysis (PMID: 40746175) added important nuance: ashwagandha produced significant, measurable cortisol reduction — but did not consistently reduce perceived stress. The biological marker moved. The subjective experience did not always follow in the same direction. This is a clinically important distinction: cortisol is one input into the experience of stress. It is not the whole picture.

For sleep, a 2021 meta-analysis (PMID: 34559859) confirmed improved sleep quality, with stronger effects in those who already had documented sleep difficulties. A 2020 RCT (PMID: 32540634, n=150) reinforced this in healthy adults taking 300mg of standardised root extract before bed.

For physical performance, a 2020 meta-analysis (PMID: 32316411) found that ashwagandha improved VO2max across pooled trials — making it one of the few adaptogens with meaningful athletic performance data.

A 2025 RCT (PMID: 41635453) added further evidence for stress and weight management, reporting significant reductions in both stress scores and body weight over a 12-week intervention period.

Important Limitations

Many RCTs use different proprietary extracts — KSM-66, Sensoril, and generic root powder — with different withanolide concentrations, making cross-study comparisons difficult. FSANZ has no specific permitted health claims for ashwagandha in Australia. Root-only extracts (which Teelixir uses) have the strongest traditional and clinical precedent — leaf-derived extracts often have different withanolide profiles.

What This Means in Practice

For Cognitive Sharpness and Mental Clarity

Lion's Mane is the better-supported choice here. Three well-designed RCTs (PMID: 38004235, 40276537, 31413233) demonstrate measurable cognitive effects in humans. Start with 500mg–1,000mg of dual-extracted fruiting body daily. Most chronic benefits appear between weeks four and eight, though some users notice acute effects within hours.

Who it may not help: If your brain fog is primarily driven by chronic stress, poor sleep, or HPA axis dysregulation, Lion's Mane alone may be insufficient. Addressing the upstream cause — often cortisol and sleep quality — typically comes first. In this scenario, ashwagandha may be more appropriate as the primary tool.

Cautions: Avoid if you have a mushroom allergy. Exercise caution alongside anticoagulant medications (theoretical interaction with platelet function, not confirmed in humans). Not recommended before surgery. Consult your healthcare professional if pregnant or breastfeeding.

For Stress, Anxiety, and Sleep

Ashwagandha. The meta-analytic data for stress and anxiety (PMID: 39348746) and sleep quality (PMID: 34559859) is more consistent than the human evidence for Lion's Mane in these areas. For sleep specifically, 300mg of standardised root extract taken in the evening is the most commonly studied effective dose (PMID: 32540634).

Who it may not help: The 2025 meta-analysis (PMID: 40746175) showed that ashwagandha moved cortisol biomarkers but did not reliably reduce the subjective experience of stress across all participants. If your stress is largely circumstantial — driven by workload, relationships, or external events rather than physiological HPA dysregulation — ashwagandha is unlikely to be sufficient on its own.

Cautions: Ashwagandha is contraindicated during pregnancy. It may interact with thyroid medications (both hypo- and hyperthyroid presentations). Those with autoimmune conditions including Hashimoto's, lupus, or rheumatoid arthritis should consult a healthcare practitioner before use. Avoid combining with sedative medications.

For Athletic Performance

Ashwagandha. The VO2max meta-analysis (PMID: 32316411) is relatively robust for this population. There is no meaningful research suggests benefits for Lion's Mane improving exercise performance or physical output. Ashwagandha's cortisol-modulating effects may also support recovery by reducing exercise-induced stress signalling.

Which One Is Right for You?

Can You Take Both? The NGF-Cortisol Stack

Yes. This is arguably where both supplements shine most — not as alternatives, but as complementary layers.

The NGF-Cortisol Effect works like this: chronic elevated cortisol has been shown in animal research to impair hippocampal neurogenesis and reduce NGF signalling. If ashwagandha is reducing cortisol, it may be creating a more permissive environment for Lion's Mane's NGF-stimulating mechanisms to take effect. Conversely, a sharper, more resilient neural architecture may improve how you process and respond to stressors.

There are no human clinical trials directly examining the Lion's Mane plus ashwagandha combination. The proposed synergy is mechanistically plausible but not clinically confirmed. We are transparent about this distinction.

A common timing approach: Lion's Mane in the morning (cognitive clarity, NGF stimulation during the active part of the day) and ashwagandha in the evening (cortisol modulation, sleep preparation). This timing is based on pharmacological profiles and traditional use patterns — not on head-to-head combination RCT data.

Starting dose if combining: Start one at a time, not both simultaneously, so you can assess individual response. Introduce Lion's Mane first (500mg daily for two weeks), then add ashwagandha (300mg in the evening). After four weeks on both, evaluate your response before adjusting.

What We Use at Teelixir

Both products in our range are relevant to this comparison — and we've applied consistent sourcing principles to each.

Our Organic Lion's Mane Extract Powder is a 10:1 dual extract (hot water + ethanol extraction) from 100% fruiting body — not mycelium on grain, which dilutes bioactive content. Batch COA C24051507 shows 31.7% beta-glucans. Heavy-metal tested to below detection limits. E. coli and Salmonella negative. Di Tao sourced from the ancestral growing regions of China, where wild Lion's Mane grows on hardwood trees at altitude.

Our Ashwagandha Root Powder is ACO certified organic and uses root-only material — not leaf, which has a different withanolide profile and weaker traditional precedent. 10:1 concentrated extract, standardised to 2.5% withanolides. Many products on the Australian market use non-organic extraction or leaf material to drive withanolide percentages up artificially. Ours maintains full-spectrum root quality. Sourced from certified organic farms in Rajasthan, India.

The Bottom Line

Remember The NGF-Cortisol Effect. Lion's Mane builds. Ashwagandha calms. Neither is universally "better" — they answer different questions.

If your primary concern is cognitive clarity, focus, and long-term neuroprotection: start with Lion's Mane. If your primary concern is stress, sleep quality, or athletic recovery: start with ashwagandha. If you want both cognitive clarity and stress resilience: the combination is mechanistically rational, practically simple, and well-tolerated at standard doses.

The question to ask is not "which is better?" but "what problem am I trying to solve?" That answer points directly to your starting point.

This article is for general information purposes only and is not intended to diagnose, treat, cure, or prevent any disease or health condition. Always consult a qualified healthcare professional before making changes to your diet, lifestyle, or supplement routine. Individual results may vary.

Related reading: Lion's Mane Benefits Guide · Lion's Mane Dosage Guide · Ashwagandha Benefits · Lion's Mane Ultimate Guide

---

Continue Your Research

• Lion's Mane Benefits: What 571 Studies Actually Show
• Lion's Mane vs Cordyceps: Brain Power or Physical Energy?
• Lion's Mane vs Reishi: Which Medicinal Mushroom Is Right for You?
• Lion's Mane vs Chaga: Cognitive Support or Antioxidant Power?
• Lion’s Mane vs Turkey Tail: Brain Support or Immune Defence?
• Lion's Mane vs Bacopa Monnieri: Two Nootropics, Two Pathways
• Lion's Mane vs Ginkgo Biloba: Neurogenesis or Cerebral Blood Flow?
• Lion's Mane Dosage Guide: Clinical Trial Doses, Extract Conversions & Timing

← Back to Lion's Mane Research Hub